Clinical Trial Update: Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial in pediatric patients with recurrent high-grade glioma evaluating hematopoietic stem cell therapy in combination with PD-1 blockade (a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Ependymoma
• Glioblastoma
• High-grade Glioma
• Oligoastrocytoma
• Oligodendroglioma
• Oligodendroglioma Anaplastic

Drugs mentioned

• PD-1 blockade (monoclonal antibody)

Snippet

Sponsor: University of Florida | Conditions: Recurrent High-grade Glioma, Grade III Astrocytoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING